News

• Kanceras ROR project has been selected for presentation at the ASCO annual meeting in Chicago.

  18 April 2012

• Kancera’s ROR inhibitors show superior efficacy in 3D pancreatic tumor model.

  21 March 2012

• Full Year Report 2011 for Kancera AB (publ)

  23 February 2012

• Kancera’s ROR-inhibitor provides higher specificity than competing products

  10 February 2012

• Kancera file patents for ROR inhibitors against cancer

  3 February 2012

• Kanceras strategy is given attention when global expertise in cancer gathers in Washington DC

  2 February 2012

• iNovacia announces collaboration with Agios Pharmaceuticals

  27 January 2012

• Kancera strengthens its patent portfolio in cancer metabolism

  23 December 2011

• iNovacia, GE Healthcare and scientists at Karolinska Institutet collaborate to advance drug discovery strategies

  8 December 2011

• Further clinical support for ROR1 as a diagnostic tool and therapeutic target

  6 December 2011